Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up.

por de Mascarel, I., Bonichon, F., Coindre, J. M., Trojani, M.
Publicado 1992

Micrometastases to axillary lymph nodes from invasive lobular carcinoma of breast: detection by immunohistochemistry and prognostic significance.

por Trojani, M., de Mascarel, I., Coindre, J. M., Bonichon, F.
Publicado 1987

Micrometastases to axillary lymph nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance.

por Trojani, M., de Mascarel, I., Bonichon, F., Coindre, J. M., Delsol, G.
Publicado 1987

Variation of hormonal receptor, pS2, c-erbB-2 and GSTpi contents in breast carcinomas under tamoxifen: a study of 74 cases.

por Soubeyran, I., Quénel, N., Mauriac, L., Durand, M., Bonichon, F., Coindre J-M
Publicado 1996

Expression of MDR1/P glycoprotein in human sarcomas.

por Vergier, B., Cany, L., Bonnet, F., Robert, J., de Mascarel, A., Coindre, J. M.
Publicado 1993

pS2 protein: a marker improving prediction of response to neoadjuvant tamoxifen in post-menopausal breast cancer patients.

por Soubeyran, I., Quénel, N., Coindre, J. M., Bonichon, F., Durand, M., Wafflart, J., Mauriac, L.
Publicado 1996

Primary chemotherapy in breast invasive carcinoma: predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erbB-2, MiB1, pS2 and GST pi.

por MacGrogan, G., Mauriac, L., Durand, M., Bonichon, F., Trojani, M., de Mascarel, I., Coindre, J. M.
Publicado 1996

Prognostic variables for the selection of patients with operable soft tissue sarcomas to be considered in adjuvant chemotherapy trials.

por Ravaud, A., Bui, N. B., Coindre, J. M., Lagarde, P., Tramond, P., Bonichon, F., Stöckle, E., Kantor, G., Trojani, M., Chauvergne, J.
Publicado 1992

Clear Cell Sarcoma (Malignant Melanoma) of Soft Parts: A Clinicopathologic Study of 52 Cases

por Hocar, O., Le Cesne, A., Berissi, S., Terrier, P., Bonvalot, S., Vanel, D., Auperin, A., Le Pechoux, C., Bui, B., Coindre, J. M., Robert, C.
Publicado 2012

DNA topoisomerase IIα expression and the response toprimary chemotherapy in breast cancer

por MacGrogan, G, Rudolph, P, Mascarel, I de, Mauriac, L, Durand, M, Avril, A, Dilhuydy, J M, Robert, J, Mathoulin-Pélissier, S, Picot, V, Floquet, A, Sierankowski, G, Coindre, J M
Publicado 2003

Prognosis and predictive value of KIT exon 11 deletion in GISTs

por Bachet, J-B, Hostein, I, Le Cesne, A, Brahimi, S, Beauchet, A, Tabone-Eglinger, S, Subra, F, Bui, B, Duffaud, F, Terrier, P, Coindre, J-M, Blay, J-Y, Emile, J-F
Publicado 2009

Summary of the Standards, Options and Recommendations for the management of patients with carcinoma of unknown primary site (2002)

por Bugat, R, Bataillard, A, Lesimple, T, Voigt, J J, Culine, S, Lortholary, A, Merrouche, Y, Ganem, G, Kaminsky, M C, Negrier, S, Perol, M, Laforêt, C, Bedossa, P, Bertrand, G, Coindre, J M, Fizazi, K
Publicado 2003

Expression and prognostic significance of PDGF ligands and receptors across soft tissue sarcomas

por Brahmi, M., Lesluyes, T., Dufresne, A., Toulmonde, M., Italiano, A., Mir, O., Le Cesne, A., Valentin, T., Chevreau, C., Bonvalot, S., Penel, N., Coindre, J.-M., Le Guellec, S., Le Loarer, F., Karanian, M., Blay, J.-Y., Chibon, F.
Publicado 2021

High frequency of β-catenin heterozygous mutations in extra-abdominal fibromatosis: a potential molecular tool for disease management

por Dômont, J, Salas, S, Lacroix, L, Brouste, V, Saulnier, P, Terrier, P, Ranchère, D, Neuville, A, Leroux, A, Guillou, L, Sciot, R, Collin, F, Dufresne, A, Blay, J-Y, Le Cesne, A, Coindre, J-M, Bonvalot, S, Bénard, J
Publicado 2010

Specific immune landscapes and immune checkpoint expressions in histotypes and molecular subtypes of sarcoma

por Dufresne, A., Lesluyes, T., Ménétrier-Caux, C., Brahmi, M., Darbo, E., Toulmonde, M., Italiano, A., Mir, O., Le Cesne, A., Le Guellec, S., Valentin, T., Chevreau, C., Bonvalot, S., Robin, Y.M., Coindre, J-M, Caux, C., Blay, J.Y., Chibon, F.
Publicado 2020